1,999,416 Indivior PLC $INDV Shares Acquired by Assenagon Asset Management S.A.

Key Points

• Assenagon Asset Management increased its Indivior stake by 129.8%, acquiring 1,999,416 shares to own 3.54 million shares, or 3% of the company. Institutional investors collectively hold 60.33% of Indivior.
• Indivior shares were trading at $32.45, down 3.5%, and remain below their 50-day and 200-day moving averages. The company reported quarterly revenue of $343 million and earnings of $5.75 per share.
• The company announced a special dividend of $8.13 per share, while analysts maintained a generally positive outlook with a consensus “Buy” rating and a $45.17 price target.

Assenagon Asset Management S.A. lifted its holdings in Indivior PLC (NASDAQ:INDV - Free Report) by 129.8% during the third quarter, according to its most recent Form 13F filing with the SEC. The firm owned 3,540,344 shares of the company's stock after purchasing an additional 1,999,416 shares during the period. Assenagon Asset Management S.A. owned 3.00% of Indivior worth $126,921,000 as of its most recent filing with the SEC.

Several other hedge funds and other institutional investors have also modified their holdings of the stock. HighTower Advisors LLC acquired a new stake in shares of Indivior during the second quarter worth approximately $3,409,000. UBS AM a distinct business unit of UBS ASSET MANAGEMENT AMERICAS LLC bought a new position in Indivior in the 2nd quarter valued at $7,988,000. VIRGINIA RETIREMENT SYSTEMS ET Al acquired a new stake in Indivior in the second quarter worth about $3,332,000. Cookson Peirce & Co. Inc. bought a new stake in shares of Indivior during the second quarter worth approximately $1,390,000. Finally, Wellington Management Group LLP bought a new stake in shares of Indivior during the 2nd quarter valued at $1,870,000. Institutional investors and hedge funds own 60.33% of the company's stock.

Indivior Trading Down 3.5%

NASDAQ INDV opened at $32.45 on Friday. Indivior PLC has a 12 month low of $23.72 and a 12 month high of $42.81. The stock has a 50 day moving average of $35.90 and a 200-day moving average of $36.72. The company has a market cap of $3.83 billion, a PE ratio of 9.21 and a beta of 0.87.

Indivior (NASDAQ:INDV - Get Free Report) last issued its earnings results on Tuesday, June 30th. The company reported $5.75 earnings per share for the quarter. Indivior had a net margin of 26.65% and a negative return on equity of 283.11%. The business had revenue of $343.00 million for the quarter. As a group, sell-side analysts predict that Indivior PLC will post 3.66 EPS for the current fiscal year.

Indivior Announces Dividend

The firm also recently announced a special dividend, which will be paid on Friday, November 6th. Stockholders of record on Friday, October 30th will be issued a dividend of $8.13 per share. The ex-dividend date of this dividend is Friday, October 30th.

Analysts Set New Price Targets

Several equities analysts have recently issued reports on the company. Barclays decreased their target price on Indivior from $46.00 to $43.00 and set an "overweight" rating for the company in a research report on Wednesday, August 5th. Zacks Research upgraded shares of Indivior from a "hold" rating to a "strong-buy" rating in a research report on Friday, October 2nd. Weiss Ratings lowered shares of Indivior from a "buy (b-)" rating to a "hold (c+)" rating in a research note on Thursday, September 24th. Finally, Craig Hallum restated a "buy" rating and set a $53.00 price objective on shares of Indivior in a report on Tuesday, August 4th. One analyst has rated the stock with a Strong Buy rating, five have assigned a Buy rating and one has given a Hold rating to the company's stock. According to MarketBeat, Indivior has an average rating of "Buy" and a consensus target price of $45.17.

Insider Buying and Selling

In related news, CAO Woodrow D. Anderson purchased 1,500 shares of the company's stock in a transaction that occurred on Thursday, August 27th. The stock was acquired at an average price of $35.69 per share, with a total value of $53,535.00. Following the completion of the purchase, the chief accounting officer directly owned 27,638 shares in the company, valued at $986,400.22. This trade represents a 5.74% increase in their ownership of the stock. The purchase was disclosed in a document filed with the Securities & Exchange Commission, which is available through the SEC website. 0.74% of the stock is currently owned by company insiders.

About Indivior

Indivior PLC NASDAQ: INDV is a specialty pharmaceutical company focused on developing and commercializing treatments for substance use disorders and serious mental health conditions. The company's primary focus is opioid use disorder, with products designed to support patients through medication-assisted treatment and recovery.

Indivior's portfolio includes Sublocade, an extended-release injectable formulation of buprenorphine; Suboxone, a buprenorphine and naloxone product available in sublingual formulations; and Perseris, an extended-release injectable formulation of risperidone for schizophrenia.

Want to see what other hedge funds are holding INDV? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for Indivior PLC (NASDAQ:INDV - Free Report).

This instant news alert was generated by narrative science technology and financial data from MarketBeat in order to provide readers with the fastest reporting and unbiased coverage. Please send any questions or comments about this story to contact@marketbeat.com.